FDA grant aims to foster innovation in pediatric medical devices

The FDA’s Office of Orphan Products Development is continuing to funnel money into organizations that support an unmet need: innovation in pediatric devices.

For the third time since 2009, FDA has awarded nearly $3 million in grants to seven consortiums that advance the development of pediatric medical devices. Each consortium is required to bring together interdisciplinary teams with experience in delivering business, regulatory, legal, scientific, engineering and clinical services for children.

“These consortia will support pediatric medical device progression through all stages of development—concept formation, prototyping, preclinical, clinical, manufacturing, marketing and commercialization,” according to the agency. “At each stage the consortia will assess and provide meaningful feedback about the scientific and medical merit of proposed pediatric device projects.”

Recipients of the funding include:

  • University of Michigan Pediatric Device Consortium, $700,000 per year
  • Atlantic Pediatric Device Consortium, $700,000 per year
  • National Capital Consortium for Pediatric Device Innovation, $700,000 per year
  • New England Pediatric Device Consortium, $700,000 per year
  • Southern California Center for Technology and Innovation in Pediatrics, $300,000 per year
  • Philadelphia Regional Pediatric Medical Device Consortium, $300,000 per year
  • Boston Pediatric Device Consortium, $200,000 per year

More information on the program is available here.

 

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.